Sickle cell disease–related clinical events reported in the Belgian Registry in patients on hydroxyurea
| Type of event . | Adverse events (no.) . | Rate/100 patient-years . |
|---|---|---|
| No. of hospitalizations* | 271 | 106 |
| ACS | 9 | 3.5 |
| Parvovirus infection with aplastic crisis | 3 | 1.2 |
| Papillary necrosis | 2 | 0.8 |
| Surgery for gallstones | 2 | 0.8 |
| Splenic sequestration | 1 | 0.4 |
| TIA or stroke | 0 | 0 |
| Osteonecrosis | 0 | 0 |
| Priapism | 0 | 0 |
| Type of event . | Adverse events (no.) . | Rate/100 patient-years . |
|---|---|---|
| No. of hospitalizations* | 271 | 106 |
| ACS | 9 | 3.5 |
| Parvovirus infection with aplastic crisis | 3 | 1.2 |
| Papillary necrosis | 2 | 0.8 |
| Surgery for gallstones | 2 | 0.8 |
| Splenic sequestration | 1 | 0.4 |
| TIA or stroke | 0 | 0 |
| Osteonecrosis | 0 | 0 |
| Priapism | 0 | 0 |
Mainly for vaso-occlusive crises, but hospitalizations for surgery or infection are also included.
ACS indicates acute chest syndrome; TIA, transient ischemic attack.